tiprankstipranks
Trending News
More News >
PZ Cussons PLC (GB:PZC)
LSE:PZC

PZ Cussons (PZC) AI Stock Analysis

Compare
53 Followers

Top Page

GB:PZC

PZ Cussons

(LSE:PZC)

Select Model
Select Model
Select Model
Neutral 54 (OpenAI - 5.2)
Rating:54Neutral
Price Target:
76.00 p
â–²(5.12% Upside)
Action:ReiteratedDate:02/11/26
The score is held back primarily by weak underlying profitability and cash-flow quality in the financial statements. Technicals are constructive with a clear uptrend, but momentum appears stretched. Valuation is mixed (strong yield but negative P/E), while the earnings call adds moderate support from upgraded guidance and deleveraging, tempered by FX and H2 execution/phasing risks.
Positive Factors
Broad-based like-for-like revenue growth
Sustained 9.5% like‑for‑like growth across multiple regions and lead markets indicates resilient brand demand and diversified geographic exposure. This durable top-line momentum supports scale economics, steadier distributor/retailer relationships, and provides a platform for continued investment in innovation and brand building.
Upgraded full‑year operating profit guidance
Management raising FY operating profit guidance reflects improving operating leverage and confidence in cost initiatives. Coupled with targeted £5–10m cost savings, this suggests a structural trajectory toward higher operating margins if execution holds, improving sustainable earnings power over the medium term.
Deleveraging and stronger cash generation
Material disposal proceeds and positive H1 free cash flow reduced leverage, enhancing financial flexibility. Lower net debt and pro‑forma leverage below 1x improve resilience to FX and emerging‑market volatility, enable reinvestment in marketing/innovation, and reduce refinancing risk over the next several quarters.
Negative Factors
Weak profitability metrics
Despite solid gross margins, the company reports negative net margin and weak ROE, reflecting overhead, tax/minority leakage and operating inefficiencies. These structural profitability gaps limit free cash flow generation and shareholder returns unless fixed costs, tax profile or minority impacts are meaningfully addressed.
Earnings aided by FX revaluation swing
A sizable portion of H1 profit came from FX accounting rather than core operations, introducing volatility and reducing clarity on organic performance. Reliance on translation gains can mask operational issues and makes future earnings less predictable if currency movements reverse or are not sustainable.
Inventory and brand execution headwinds
Elevated inventories and channel-specific overhangs (including St.Tropez weakness outside the U.S.) pressurize sales, require promotional actions, and tie up working capital. These structural channel and inventory mismatches can erode margins and slow the pace of sustainable revenue recovery if not resolved.

PZ Cussons (PZC) vs. iShares MSCI United Kingdom ETF (EWC)

PZ Cussons Business Overview & Revenue Model

Company DescriptionPZ Cussons Plc manufactures, distributes, markets, and sells baby, beauty, and hygiene products in Europe, the Americas, the Asia Pacific, and Africa. It offers toiletries, pharmaceuticals, electrical goods, fats and spreads, nutritional products, shampoos, body washes, toothpastes, toothbrushes, skin and hair care, food pouches, cereals, snacks, flavors, and fragrances; beauty soaps, lotions, wipes, creams, shower gels, foam-bursts, bar soaps, deodorants, bath infusions, handwashes, and conditioners; dishwashing liquids, dishwasher tablets, dishwasher gels, dishwasher capsules, rinse aids, liquid detergents, laundry soaps, and laundry solutions; and cooking and vegetable oils. The company also provides refrigerators, freezers and air conditioners, washing machines, microwaves, table and standing cookers, generators, stabilizers, TVs, DVDs, and home theatres. It sells its products under the Cussons Kids, Rafferty's Garden, Cussons Baby, St.Tropez, Sanctuary Spa, Fudge Professional, Charles Worthington, Fudge Urban, Venus for You, Carex, Imperial Leather, Original Source, Premier Cool, Joy, Premier Cool, Haier Thermocool, Morning Fresh, Bayley's of Bond Street, Canoe, Zip, Robb, Radiant, Mamador, and Devon King's brand names. The company was formerly known as Paterson Zochonis Plc and changed its name to PZ Cussons Plc in 2002. PZ Cussons Plc was incorporated in 1884 and is headquartered in Manchester, the United Kingdom.
How the Company Makes MoneyPZ Cussons makes money by selling branded fast-moving consumer goods (FMCG) across personal care, home care, and food & nutrition categories. Revenue is generated mainly from the wholesale and retail sale of products it manufactures itself (and, where applicable, products it sources/outsources and distributes under its brands) to a mix of customers that typically includes large modern trade retailers, traditional trade wholesalers/distributors, and other local channels. The company’s earnings are driven by (1) product volume sold, (2) pricing and product mix (premium vs. value offerings), and (3) the strength of brand-driven repeat purchasing in everyday-use categories such as soaps, detergents, toiletries, and related household goods; where it participates in food/nutrition, sales are similarly driven by consumer staples and nutrition-oriented packaged products. Profitability depends on its ability to manage input costs (raw materials, packaging, and logistics), maintain manufacturing efficiency, and fund brand-building (marketing and promotion) to defend market share. Material factors that can significantly affect reported results include foreign exchange movements and macroeconomic conditions—particularly in Nigeria—because they influence local currency revenues, import/input costs, and the translation of earnings into the group’s reporting currency.

PZ Cussons Earnings Call Summary

Earnings Call Date:Feb 11, 2026
(Q2-2026)
|
% Change Since: |
Next Earnings Date:Sep 23, 2026
Earnings Call Sentiment Positive
The call presents a constructive and improving financial picture: double-digit-like LFL revenue growth (9.5%), materially higher adjusted operating profit, strengthened balance sheet and reduced leverage following disposals, plus clear brand and geographic wins (Sanctuary Spa, ANZ, Nigeria recovery, St.Tropez U.S.). However, there are important caveats — a portion of the H1 profit improvement was driven by FX revaluation swings, St.Tropez underperformed outside the U.S., gross margin was compressed by mix effects, and the company will intentionally reduce near-term profits in H2 to fund higher marketing investment and work through inventory/seasonality. On balance the positives (broad-based revenue growth, margin improvement, deleveraging, upgraded guidance and cash generation) outweigh the negatives, but the narrative remains guarded with execution and FX volatility risks to monitor.
Q2-2026 Updates
Positive Updates
Strong Group Revenue Growth
Group revenue GBP 269m vs GBP 249m prior year; like-for-like revenue growth 9.5% driven by broad-based growth across all 3 reporting regions, 4 lead markets (U.K., Australia, Indonesia, Nigeria) and top 10 brands.
Improved Adjusted Operating Profit and Margin
Adjusted operating profit increased to GBP 36m from GBP 27m a year ago; operating margin improved by c.240 basis points (and by c.430 bps on a continuing operations basis excluding PZ Wilmar).
Upgraded Full-Year Operating Profit Guidance
Full-year adjusted operating profit guidance increased to GBP 53–57m (from GBP 50–55m previously) reflecting confidence in FY26 performance despite H2 phasing.
Balance Sheet Strengthening and Deleveraging
Proceeds from disposals (including sale of 50% stake in PZ Wilmar) materially improved the balance sheet: reported net debt reduced to GBP 84m (net leverage 1.1x) and pro forma net debt c. GBP 48m after further receipts, with leverage below 1x.
Cash Generation and Disposal Proceeds
Free cash flow GBP 23m in H1 plus GBP 27.6m of cash proceeds from asset sales in the period (GBP 15.8m surplus assets; GBP 11.8m initial Wilmar tranche) and further Wilmar cash receipts since period end.
Strong Performance in Africa (Nigeria)
African revenues GBP 79m with like-for-like growth 28% (reported growth ~30%) driven by annualization of prior pricing and return to volume growth; company expects sustainable low-to-mid-teens operating margins in the region assuming current FX and business performance.
Standout Brand and Market Wins
Sanctuary Spa grew c.30% driven by a record Christmas gifting period (Christmas revenue >30% up; shipped 98% of Christmas packs before December). ANZ delivered its third consecutive quarter of revenue growth; St.Tropez grew +12% in the U.S. following transition to The Emerson Group.
Cost Savings and Overhead Reduction
Company is delivering targeted cost savings of GBP 5–10m in FY26; central adjusted loss reduced by GBP 4.6m due to FX and people/process savings; marketing spend was lower in H1 (to be weighted to H2).
Negative Updates
St.Tropez Underperformance Outside U.S.
Overall St.Tropez revenue declined 11% in H1 and in some markets revenue was down over 30% (inventory overhang and need to win back retail support); brand did not grow absolute H1 revenue and remains a turnaround work in progress despite +12% in the U.S.
Reliance on FX Revaluation Swing
Around GBP 6m of the H1 operating profit improvement related to FX revaluation gains on USD-denominated liabilities in Nigeria (a year-on-year swing partly reflecting prior year naira depreciation); management cautions this is a timing/accounting effect and not a recurring operational gain.
Gross Margin Compression from Geographic Mix
Gross margin declined as higher-growth Nigeria (structurally lower margin) comprised a greater share of revenue growth, partially offset by overhead reductions.
Higher Tax Charge and Minority Leakage Impacting EPS
Adjusted PBT increased to GBP 30m (from GBP 20m) but adjusted EPS growth was muted due to a higher group tax charge (more profits from Nigeria where tax has normalized) and minority interest leakage in Nigeria; dividend held flat at 1.5p.
APAC Adjusted Profit Decline and Legacy Charges
APAC revenue LFL +5.2% (flat in reported currency) but adjusted operating profit declined by GBP 1m, including legacy VAT charges in smaller Asian businesses.
Inventory and Seasonality Headwinds
High levels of inventory (notably Amazon/UK and St.Tropez) weighed on reported revenue in H1; company is working to reduce inventory but this contributed to weaker sales in some channels and markets.
H2 Profit Phasing and Increased Marketing Spend
Guidance implies a year-on-year decline in profit in H2 due to a significant planned step-up in marketing and promotional investment (company expects heavier H2 M&C spend and to reinvest behind seasonal campaigns and innovation).
Ongoing FX and Emerging Market Risks
Exposure to currency volatility (naira, AUD, IDR) remains a risk; while Indonesia currently shows no material trading disruption from recent unrest, Moody's downgrade and emerging-market volatility are cited as ongoing risks and require continued guardrails and balance-sheet management.
Company Guidance
Management raised full‑year adjusted operating profit guidance to £53–57m (from £50–55m) while reiterating FY‑26 cost‑savings of £5–10m and a progressive capital allocation policy; H1 delivered revenue £269m (+9.5% LFL), adjusted operating profit £36m (vs £27m), adjusted PBT £30m (vs £20m), adjusted EPS 4.37p, free cash flow £23m and an unchanged dividend of 1.5p. Balance‑sheet moves included £27.6m of disposal proceeds in the period, net debt down to £84m (net leverage 1.1x; on a conservative basis excluding Nigerian cash 1.4x) and a pro‑forma net debt of £48m (leverage <1x) after a further £37m Wilmar receipt; H1 also benefitted from a c.£6m FX revaluation swing (c.£2m credit this year versus c.£4m debit prior) but guidance does not assume an additional £2m FX benefit. Regional notes underpinning the guidance: Africa LFL revenue +28% with Nigeria margin around c.14% and a sustainable low–mid‑teen margin if the naira holds, APAC and EMEA momentum but marketing spend is being back‑weighted to H2 (a significant step‑up), and CapEx was £1m in H1 with normal levels expected for the full year.

PZ Cussons Financial Statement Overview

Summary
Mixed fundamentals: modest revenue growth but weak profitability (negative net margin and ROE) and pressured cash generation (declining free cash flow and low operating cash flow vs net income). Balance sheet leverage looks manageable, but overall financial quality remains below average.
Income Statement
45
Neutral
PZ Cussons shows a mixed performance in its income statement. The company has experienced a slight revenue growth of 2.74% in the most recent year, but it has struggled with profitability, as indicated by a negative net profit margin of -1.13%. The gross profit margin is relatively healthy at 40.25%, but the EBIT and EBITDA margins are modest at 8.54% and 10.10%, respectively. The company needs to address its profitability challenges to improve its financial health.
Balance Sheet
50
Neutral
The balance sheet of PZ Cussons reflects moderate financial stability. The debt-to-equity ratio stands at 0.78, indicating a manageable level of leverage. However, the return on equity is negative at -2.64%, highlighting inefficiencies in generating returns for shareholders. The equity ratio is not explicitly provided, but the company's total assets and equity suggest a reasonable level of equity financing. Overall, the balance sheet shows stability but lacks strong profitability.
Cash Flow
40
Negative
PZ Cussons faces challenges in its cash flow management. The free cash flow growth rate is negative at -5.68%, indicating a decline in cash generation. The operating cash flow to net income ratio is low at 0.10, suggesting limited cash flow relative to net income. The free cash flow to net income ratio is healthier at 0.71, but overall cash flow performance needs improvement to support long-term financial health.
BreakdownTTMMay 2025May 2024May 2023May 2022May 2021
Income Statement
Total Revenue533.80M513.80M527.90M656.30M592.80M603.30M
Gross Profit206.20M206.80M131.10M238.20M207.30M216.30M
EBITDA68.40M51.90M-55.30M86.10M81.50M89.80M
Net Income-4.90M-5.80M-57.00M36.40M47.90M36.90M
Balance Sheet
Total Assets644.30M615.20M649.60M988.40M941.90M780.50M
Cash, Cash Equivalents and Short-Term Investments49.90M45.10M51.30M256.90M164.30M87.30M
Total Debt159.50M172.00M178.70M264.20M191.00M129.80M
Total Liabilities410.50M401.70M414.40M566.30M493.00M409.00M
Stockholders Equity234.80M219.70M242.30M395.60M427.00M352.70M
Cash Flow
Free Cash Flow14.80M16.60M6.80M51.50M44.90M43.10M
Operating Cash Flow21.20M23.50M12.90M58.20M53.10M52.00M
Investing Cash Flow24.60M700.00K12.40M19.50M-5.70M2.70M
Financing Cash Flow-45.60M-28.70M-109.70M43.30M26.60M-38.60M

PZ Cussons Technical Analysis

Technical Analysis Sentiment
Negative
Last Price72.30
Price Trends
50DMA
76.46
Negative
100DMA
74.61
Positive
200DMA
72.75
Positive
Market Momentum
MACD
-0.73
Positive
RSI
38.81
Neutral
STOCH
12.38
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:PZC, the sentiment is Negative. The current price of 72.3 is below the 20-day moving average (MA) of 81.33, below the 50-day MA of 76.46, and below the 200-day MA of 72.75, indicating a neutral trend. The MACD of -0.73 indicates Positive momentum. The RSI at 38.81 is Neutral, neither overbought nor oversold. The STOCH value of 12.38 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:PZC.

PZ Cussons Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
£169.65M15.5125.14%5.97%6.38%-10.55%
72
Outperform
£17.82M4.669.67%3.17%2.83%―
71
Outperform
£105.64B20.3328.78%3.85%-2.98%-16.90%
66
Neutral
£235.54M3.9142.11%2.12%-0.89%1.30%
66
Neutral
£34.53B12.3038.45%3.44%-2.41%-16.41%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
54
Neutral
£313.78M14.34-2.16%4.82%-2.67%89.86%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:PZC
PZ Cussons
74.80
0.16
0.22%
GB:CRL
Creightons
26.00
-2.60
-9.09%
GB:MCB
McBride
140.80
0.46
0.33%
GB:ULVR
Unilever
4,834.50
24.35
0.51%
GB:W7L
Warpaint London
210.00
-145.20
-40.88%
GB:RKT
Reckitt
5,356.00
388.62
7.82%

PZ Cussons Corporate Events

Other
PZ Cussons Chair David Tyler Buys 50,000 Shares
Positive
Mar 3, 2026

PZ Cussons’ non-executive chair, David Tyler, has purchased 50,000 ordinary shares of 1 pence each in the company on 3 March 2026 at a price of £0.795 per share. The on-market transaction on the London Stock Exchange increases Tyler’s personal stake in the business, a move likely to be interpreted by investors as a sign of confidence in the company’s prospects and governance.

This share purchase by the board chair underscores board-level alignment with shareholders at a time when investor scrutiny of corporate leadership and capital allocation remains high. While no additional strategic commentary accompanied the disclosure, such director dealings are closely watched in the consumer goods sector as potential indicators of management’s outlook on valuation and future performance.

The most recent analyst rating on (GB:PZC) stock is a Buy with a £91.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
PZ Cussons Executives Receive Shares Under 2020 Incentive Plan
Positive
Feb 19, 2026

PZ Cussons has disclosed that three senior executives, including Chief Executive Officer Jonathan Myers, Chief Supply Chain Officer Steve Noble and Company Secretary and General Counsel Kareem Moustafa, have acquired ordinary shares under the company’s Share Incentive Plan 2020. Each executive purchased 167 partnership shares at a price of £0.896016 per share and received a grant of 111 matching shares at nil cost on 17 February 2026, in transactions partly executed on the London Stock Exchange and partly outside a trading venue.

The awards modestly increase the executives’ equity exposure and further align their interests with those of shareholders, reinforcing PZ Cussons’ use of share-based incentives as a tool for management engagement and long-term value creation. While the volumes involved are small in absolute terms, such routine incentive plan transactions can signal ongoing commitment of senior leadership to the company’s strategic and financial performance, and provide incremental transparency to the market on insider dealings.

The most recent analyst rating on (GB:PZC) stock is a Buy with a £91.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Other
PZ Cussons Director Boosts Stake With Share Purchase
Positive
Feb 13, 2026

PZ Cussons has disclosed that non-executive director Vivek Ahuja purchased 20,000 ordinary shares in the company on 13 February 2026. The trade, executed on the London Stock Exchange at a price of about £0.91 per share, signals board-level confidence in the business and modestly increases insider ownership, a factor closely watched by investors assessing governance and alignment with shareholders.

The most recent analyst rating on (GB:PZC) stock is a Buy with a £91.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Other
PZ Cussons Chair David Tyler Buys 25,000 Shares
Positive
Feb 13, 2026

PZ Cussons has disclosed that its non-executive chair, David Tyler, purchased 25,000 ordinary shares in the company on 12 February 2026. The shares were acquired on the London Stock Exchange at a price of £0.909772 per share, a move that may be read by investors as a sign of confidence in the company’s prospects from its board leadership.

The most recent analyst rating on (GB:PZC) stock is a Buy with a £91.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Business Operations and StrategyDividendsFinancial Disclosures
PZ Cussons sets renewed strategy with double-digit returns target
Positive
Feb 11, 2026

PZ Cussons has outlined a renewed group strategy at a capital markets event in London, highlighting a sharper focus on building portfolios of locally loved brands across four lead markets spanning developed and emerging economies. Management presented the business as more focused and resilient following a recent strategic review that strengthened the balance sheet and sharpened its geographic and category priorities.

The company is targeting double-digit total shareholder returns through the cycle, anchored by mid-single-digit like-for-like revenue growth, high single-digit operating profit growth and high single-digit EPS growth under a new financial and value-creation framework. It also detailed a capital allocation policy that keeps net debt within a defined range, commits to a progressive dividend and reserves surplus cash for bolt-on acquisitions in priority markets, signaling an active approach to growth and returns for investors.

The most recent analyst rating on (GB:PZC) stock is a Hold with a £75.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Business Operations and StrategyDividendsFinancial DisclosuresM&A Transactions
PZ Cussons lifts profit guidance after broad-based first-half growth
Positive
Feb 11, 2026

PZ Cussons reported a strong first-half performance for the six months to 29 November 2025, with like-for-like revenue up 9.5% and growth across all four lead markets of the UK, Australia and New Zealand, Nigeria and Indonesia. Revenue rose 8% to £269.3m, adjusted operating profit jumped 31.9%, and adjusted profit before tax climbed 50.5%, helped by double-digit growth in its ten largest brands, tight cost control and non-cash FX gains linked to a stronger Nigerian naira.

The group has completed its strategic review, strengthened its balance sheet and sharpened its focus through the disposal of its 50% stake in the PZ Wilmar joint venture, which has generated £48.5m of proceeds to date and contributed to a £27.7m reduction in net debt since May 2025. Maintaining its interim dividend at 1.50p per share, the board set a new capital allocation framework targeting net debt to EBITDA of 1.0–1.5x, a progressive dividend and selective bolt-on M&A, while raising full-year adjusted operating profit guidance to £53–57m and reiterating cost-savings plans largely earmarked for reinvestment in brands and people.

The most recent analyst rating on (GB:PZC) stock is a Hold with a £75.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Executive/Board Changes
PZ Cussons Confirms Timetable for Board Departure of Sarah Pollard
Neutral
Jan 22, 2026

PZ Cussons has announced a change to its board, confirming that Sarah Pollard will step down as a director on 13 February 2026 and remain with the business until 20 March 2026 to support an orderly transition. The move signals a period of leadership handover at the consumer goods group, though the company has framed the timetable as managed and structured to minimise disruption to operations and stakeholders across its global footprint.

The most recent analyst rating on (GB:PZC) stock is a Hold with a £75.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
PZ Cussons Executives Increase Stakes Through Share Incentive Plan
Positive
Jan 20, 2026

PZ Cussons has disclosed that several senior executives, including Chief Executive Officer Jonathan Myers, Chief Financial Officer Sarah Pollard, Chief Supply Chain Officer Steve Noble and Company Secretary and General Counsel Kareem Moustafa, have acquired ordinary shares under the company’s 2020 Share Incentive Plan. On 19 January 2026 each of the executives purchased 212 partnership shares at £0.706 per share on the London Stock Exchange and received an associated grant of 141 matching shares at no cost, in transactions partly conducted on XLON and partly outside a trading venue, further increasing management’s equity participation in the group.

The most recent analyst rating on (GB:PZC) stock is a Hold with a £75.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Business Operations and StrategyExecutive/Board Changes
PZ Cussons Names Jan Bramall as New Chief Financial Officer
Positive
Dec 22, 2025

PZ Cussons has appointed Jan Bramall as its new Chief Financial Officer and Board member, effective 23 March 2026, succeeding outgoing CFO Sarah Pollard. Bramall brings extensive international finance and strategy experience from roles at Severfield, Manchester Airports Group, Tyco and Johnson Controls, and will join at what the company describes as a pivotal time following its strategic review, with the board expecting her leadership to support the next phase of growth and improved profitability.

The most recent analyst rating on (GB:PZC) stock is a Hold with a £78.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Other
PZ Cussons Executives Increase Holdings Through Share Incentive Plan
Positive
Dec 18, 2025

PZ Cussons has disclosed a series of share dealings by senior management under its Share Incentive Plan 2020, involving the chief executive officer, chief financial officer, chief supply chain officer and the company secretary and general counsel. On 17 December 2025 each of these executives purchased 200 ordinary shares at £0.75 and received 133 matching shares at no cost, in transactions partly executed on the London Stock Exchange and partly outside a trading venue, underscoring ongoing alignment between leadership and shareholders through increased equity participation.

The most recent analyst rating on (GB:PZC) stock is a Hold with a £78.00 price target. To see the full list of analyst forecasts on PZ Cussons stock, see the GB:PZC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 11, 2026